Ad is loading...
MENU
ARQT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Arcutis Biotherapeutics (ARQT) Ownership - Who owns Arcutis Biotherapeutics?
Profile
Industry
N/A
Address
3027 Townsgate Road
Phone
+1 805 418-5006
Employees
296
Web
https://www.arcutis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.2B
P/E Ratio
N/A
Total Cash
330.56M
Projected Growth
N/A
Total Debt
208.18M
Revenue
138.71M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
2.82
Total Debt/Equity
N/A
Revenue/Share
1.19 USD as % of share price
Fundamentals
ARQT
Capitalization
1.2B
P/E Ratio
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash
331M
Total Cash/Share
2.82
Total Debt
208M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.19%
Revenue
139M
ROE
N/A
Book Value
157M
P/B Ratio
7.65
Cash Flow
N/A
Earnings
-1.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
2.46
Current Revenue Per Employee
151199.33
Dividends Per Share - Security
N/A
EBITDA
-163.28M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.70
Revenue To Assets
-53.55
Shares Held By Institutions
1.59B
Shares Outstanding - Current
117M
Total Liabilities
281M
Total Volume MTD
N/A
Value
N/A
Gain YTD
217.028
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development and commercialization of treatments for dermatological diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3027 Townsgate Road
Phone
+1 805 418-5006
Employees
296
Web
https://www.arcutis.com